Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
The Meso Foundation will host a Meet the Mesothelioma Experts teleconference about making a difference through advocacy on Thursday, February 22 at 8PM ET (RSVP
During February, the Meso Foundation will be undergoing a database migration. Our previous database provider suddenly announced a discontinuation of their product, forcing us to
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.
With the conclusion of its latest funding cycle, the Mesothelioma Applied Research Foundation has reached the milestone of $10 million in grant funding awarded to
IMPORTANT: This is a new action! Even if you’ve already contacted your congressional representatives and they already cosigned the bill, please send them this message
It was recently announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) designated nintedanib, an oral triple angiokinase inhibitor by Boehringer Ingelheim,
As the holidays come around, you may not be celebrating like in years past. As a patient, you may be forced to structure the holidays
In this day and age, anyone can publish “news” online – it’s inexpensive, quick, and looks official without much of an investment from the publisher.
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
